An exploratory trial suggests ultrasound-based stiffness measurements could reveal exercise-related muscle changes in type 2 diabetes before HbA1c or muscle thickness, although clinical validation is still needed.
A small exploratory study published in BMC Endocrine Disorders suggests that shear wave elastography may detect exercise-related muscle changes in type 2 diabetes sooner than standard clinical measures. In the 12-week trial, researchers compared high-intensity interval exercise with moderate-intensity aerobic exercise and found that stiffness changes in the right gastrocnemius appeared after just one week in the high-intensity group, well before longer-term shifts in glycated haemoglobin and muscle thickness became significant.
The study involved 66 participants who completed the programme and were included in the per-protocol analysis, with 32 assigned to high-intensity interval exercise and 34 to moderate aerobic training. Measurements were taken at baseline, week one, week eight and week 12, and the investigators tracked HbA1c, the thickness of the medial head of the right gastrocnemius and shear wave velocity. They reported significant group-by-time effects across all three outcomes, suggesting that the two exercise programmes produced different patterns of change over time.
The researchers described the work as methodological rather than definitive, and they cautioned that the imaging technique has not yet been clinically validated as a stand-alone way of judging whether an exercise intervention is effective. They also noted the narrow scope of the analysis, which focused on one muscle on one side of the body, and the fact that six of the 72 enrolled participants were excluded from the final per-protocol set. Even so, the authors said the findings support further study of elastography as an early monitoring tool, provided it is backed by functional validation.
The new paper adds to a growing body of research suggesting that shear wave elastography could have broader use in diabetes care. Other recent studies have linked the technique to reduced muscle stiffness in people with type 2 diabetes, possible early detection of diabetic muscle changes, and assessment of sarcopenia, the age-related loss of muscle mass and strength. Together, those findings point to a developing role for ultrasound-based tissue assessment in spotting musculoskeletal complications before they become obvious in routine clinical testing.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
